Cannon Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,766
Closed -$676K 106
2026
Q1
$676K Buy
2,766
+34
+1% +$7.92K 0.5% 43
2025
Q4
$597K Sell
2,732
-176
-6% -$34.8K 0.42% 43
2025
Q3
$560K Buy
2,908
+604
+26% +$103K 0.38% 50
2025
Q2
$352K Sell
2,304
-121
-5% -$18.6K 0.28% 55
2025
Q1
$402K Sell
2,425
-351
-13% -$54.9K 0.37% 44
2024
Q4
$401K Sell
2,776
-39
-1% -$6.04K 0.34% 45
2024
Q3
$454K Buy
+2,815
New +$449K 0.37% 44

Other funds holding JNJ

Cannon Advisors's JNJ Position: Q2 2026 in Review

Cannon Advisors sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 2,766 shares — an estimated $676K sold.

Cannon Advisors first reported a position in JNJ in Q3 2024 and held it in 7 quarters. The position peaked at $676K in Q1 2026. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cannon Advisors reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Cannon Advisors sold 2,766 Johnson & Johnson shares in Q2 2026, an estimated $676K.
  • Cannon Advisors first reported a position in Johnson & Johnson in Q3 2024 and held it in 7 quarters.
  • Cannon Advisors's Johnson & Johnson position peaked at $676K in Q1 2026.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cannon Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.